NUVB Nuvation Bio Inc

  1. Stocks
  2. Healthcare
  3. NYSE: NUVB

Price (delayed)

$3.27

Market cap

$716.28M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.35

Enterprise value

$677.64M

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and ...

Highlights
NUVB's EPS is up by 27% YoY and by 5% QoQ
The net income has increased by 27% year-on-year and by 9% since the previous quarter
The company's quick ratio rose by 14% QoQ but it fell by 13% YoY
NUVB's equity is down by 8% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.nuvationbio.com
Peers: OMER OMGA

Key stats

What are the main financial stats of NUVB
Market
Shares outstanding
219.05M
Market cap
$716.28M
Enterprise value
$677.64M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.18
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$75.8M
EBITDA
-$75.65M
Free cash flow
-$68.05M
Per share
EPS
-$0.35
Free cash flow per share
-$0.31
Book value per share
$2.76
Revenue per share
$0
TBVPS
$2.84
Balance sheet
Total assets
$621.48M
Total liabilities
$16.36M
Debt
$4.01M
Equity
$605.12M
Working capital
$602.46M
Liquidity
Debt to equity
0.01
Current ratio
44.11
Quick ratio
43.74
Net debt/EBITDA
0.51
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-11.9%
Return on equity
-12.2%
Return on invested capital
-12.8%
Return on capital employed
-12.5%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NUVB stock price

How has the Nuvation Bio stock price performed over time
Intraday
2.19%
1 week
24.81%
1 month
-5.22%
1 year
101.85%
YTD
116.56%
QTD
-10.16%

Financial performance

How have Nuvation Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$99.82M
Net income
-$75.8M
Gross margin
N/A
Net margin
N/A
The net income has increased by 27% year-on-year and by 9% since the previous quarter
The operating income rose by 17% year-on-year and by 3.4% since the previous quarter

Growth

What is Nuvation Bio's growth rate over time

Valuation

What is Nuvation Bio stock price valuation
P/E
N/A
P/B
1.18
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
NUVB's EPS is up by 27% YoY and by 5% QoQ
The stock's price to book (P/B) is 97% more than its last 4 quarters average of 0.6
NUVB's equity is down by 8% year-on-year

Efficiency

How efficient is Nuvation Bio business performance
The return on invested capital has increased by 28% year-on-year and by 9% since the previous quarter
NUVB's ROE is up by 20% YoY and by 7% from the previous quarter
NUVB's return on assets is up by 19% year-on-year and by 6% since the previous quarter

Dividends

What is NUVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NUVB.

Financial health

How did Nuvation Bio financials performed over time
The total liabilities fell by 15% QoQ and by 4.1% YoY
The company's quick ratio rose by 14% QoQ but it fell by 13% YoY
Nuvation Bio's debt is 99% lower than its equity
Nuvation Bio's debt has decreased by 10% QoQ and by 6% YoY
NUVB's equity is down by 8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.